A. Souque

发表

Crucial role of the H11-H12 loop in stabilizing the active conformation of the human mineralocorticoid receptor.

D. Moras, J. Wurtz, D Moras, 2000, Molecular endocrinology.

Ligand-induced conformational change in the human mineralocorticoid receptor occurs within its hetero-oligomeric structure.

M. Lombès, J. Fagart, A. Souque, 1996, The Biochemical journal.

Antagonism in the human mineralocorticoid receptor

D. Moras, J. Wurtz, C. Hellal-Levy, 1998, The EMBO journal.

Treatment of murine hepatocellular carcinoma using genetically modified cells to express interleukin‐12

P. Rochaix, G. Favre, L. Buscail, 2004, Journal of gastroenterology and hepatology.

Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril.

J. Schwartz, D. Danvy, J. Lecomte, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan.

J. Schwartz, J. Lecomte, A. Souque, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Degradation of atrial natriuretic factor in mouse blood in vitro and in vivo: Role of enkephalinase (EC 3.4.24.11)

J. Schwartz, A. Souque, C. Gros, 1990, Neuropeptides.

Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity

L. Pradayrol, L. Buscail, P. Gourdy, 2006, Gut.

Gene therapy based on gemcitabine chemosensitization suppresses pancreatic tumor growth.

L. Pradayrol, L. Buscail, G. Tiraby, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Inactivation of atrial natriuretic factor in mice in vivo: crucial role of enkephalinase (EC 3.4.24.11).

J. Schwartz, A. Souque, C. Gros, 1990, European journal of pharmacology.

The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11ß-hydroxysteroid dehydrogenase

N. Farman, M. Lombès, J. Funder, 1995, Journal of endocrinological investigation.

The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11 beta-hydroxysteroid dehydrogenase.

N. Farman, M. Lombès, A. Souque, 1994, Endocrinology.

Lymphoid stromal reaction in gastrointestinal lymphomas: immunohistochemical study of 14 cases.

N. Brousse, A. Jarry, A. Souque, 1987, Journal of clinical pathology.

Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans.

R. Ardaillou, J. Lecomte, A. Souque, 1990, European journal of pharmacology.

peritoneal innate immunity genetically modified to express IL 12 : a role for peritoneal carcinomatosis with fibroblasts Treatment of experimental murine pancreatic and

L. Pradayrol, L. Buscail, P. Gourdy, 2006 .

Reversible Inhibition of the In Vitro Coagulation of Human Plasma by Lectins

J. Freyssinet, A. Souque, D. Thevenon, 1982, Thrombosis and Haemostasis.

MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.

L. Buscail, J. Selves, P. Cordelier, 2010, Clinical chemistry.

Identification of an upstream promoter of the human somatostatin receptor, hSSTR2, which is controlled by epigenetic modifications.

F. Lopez, L. Buscail, C. Susini, 2008, Endocrinology.

let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.

L. Buscail, J. Escourrou, P. Cordelier, 2009, Human gene therapy.

A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action.

M. Lombès, M. Zennaro, S. Viengchareun, 2001, Molecular endocrinology.

Photoaffinity labelling of the human mineralocorticoid receptor with steroids having a reactive group at position 3, 18 or 21.

J. Fagart, A. Souque, M. Rafestin-Oblin, 1998, Biochimica et biophysica acta.

The mineralocorticoid activity of progesterone derivatives depends on the nature of the C18 substituent.

J. Fagart, A. Souque, M. Rafestin-Oblin, 1995, Endocrinology.

Mechanistic aspects of mineralocorticoid receptor activation.

C. Hellal-Levy, J. Fagart, A. Souque, 2000, Kidney international.

Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples.

B. Lepage, P. Ruszniewski, L. Buscail, 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Characterization of the bystander effect of somatostatin receptor sst2 after in vivo gene transfer into human pancreatic cancer cells.

L. Pradayrol, N. Vaysse, L. Buscail, 2005, Human gene therapy.

A single amino acid mutation of ala-773 in the mineralocorticoid receptor confers agonist properties to 11beta-substituted spirolactones.

D. Moras, J. Wurtz, C. Hellal-Levy, 2000, Molecular pharmacology.

A Single Amino Acid Mutation of Ala-773 in the Mineralocorticoid Receptor Confers Agonist Properties to 11 b -Substituted Spirolactones

D. Moras, J. Wurtz, C. Hellal-Levy, 2000 .

Identification of steroid ligands able to inactivate the mineralocorticoid receptor harboring the S810L mutation responsible for a severe form of hypertension

A. Vandewalle, J. Fagart, A. Souque, 2004, Molecular and Cellular Endocrinology.

Specific hydroxylations determine selective corticosteroid recognition by human glucocorticoid and mineralocorticoid receptors

C. Gomez-Sanchez, C. Hellal-Levy, J. Fagart, 1999, FEBS letters.

11β-Hydroxyprogesterone Acts as a Mineralocorticoid Agonist in Stimulating Na+ Absorption in Mammalian Principal Cortical Collecting Duct Cells

A. Vandewalle, M. Bens, J. Fagart, 2002 .

Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis.

E. Assenat, P. Ruszniewski, L. Buscail, 2009, Endoscopy.

The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related.

A. Vandewalle, J. Fagart, A. Souque, 2003, Endocrinology.

Sulfhydryl groups are involved in the binding of agonists and antagonists to the human mineralocorticoid receptor

J. Fagart, A. Souque, M. Rafestin-Oblin, 1996, The Journal of Steroid Biochemistry and Molecular Biology.

11beta-hydroxyprogesterone acts as a mineralocorticoid agonist in stimulating Na+ absorption in mammalian principal cortical collecting duct cells.

A. Vandewalle, M. Bens, J. Fagart, 2002, Molecular pharmacology.